Protecting your remaining beta cells in type 1 diabetes

Yes, at the time of diagnosis most people still have 10–50% of their beta cells working, the proportion varying with age (young children lose more, young adults may retain more) [1]. Symptoms appear when beta cell mass drops below a critical threshold, which varies from person to person. C-peptide measured in the blood confirms the presence of some remaining working beta cells. Values above 0.2 nmol/L (0.6 ng/mL) indicate significant residual insulin production [2].

These remaining beta cells are very valuable even if they do not produce enough insulin to provide complete independence. They offer a kind of buffering system that smooths out blood glucose fluctuations, reducing the risk of both hypoglycemia and ketoacidosis [3]. Glycemic control is therefore easier to achieve. Studies show that people with residual beta cell function have a lower risk of long-term (chronic) complications [4].

The single most important protective factor is glycemic control [5]. Persistently high blood glucose is toxic to beta cells, and the effect is proportional to the level and duration of the hyperglycemia [6]. Aim for blood glucose between 70–140 mg/dL (3.9–7.8 mmol/L) as much as possible — a tighter target than the usual 70–180 mg/dL (3.9–10.0 mmol/L), because here the aim is to protect your remaining beta cells. This is not a guideline target: ADA 2026 recommends 80–130 mg/dL (4.4–7.2 mmol/L) before meals and under 180 mg/dL (10 mmol/L) after meals [7]. It is set together with your medical team, because tighter control raises the risk of hypoglycemia. Hypoglycemia means a blood glucose below 70 mg/dL (3.9 mmol/L): you take 15 g of fast-acting carbohydrate and recheck after 15 minutes. The complete steps are on the pages about what hypoglycemia is and about how to treat it. Episodes of ketoacidosis are worth preventing as far as possible, because acidosis and dehydration are extremely toxic to beta cells [8]. The warning signs are nausea, vomiting, deep breathing and the smell of acetone on the breath. When your blood glucose stays high or you feel unwell, measure your blood ketones. Between 1.5 and 2.9 mmol/L, contact your medical team immediately. At 3.0 mmol/L or above, or if vomiting, difficulty breathing or drowsiness appear, go to the emergency room straight away.

Adequate doses of external insulin give the beta cells a rest, reducing the stress placed on them and the strain they endure while working. Do not try to "train" your pancreas by under-dosing insulin. Studies show that starting intensive insulin treatment early maximizes the chances of preserving residual beta cell function, as the figure below shows [5].

Yes, glycemic control is the most powerful protective factor for your remaining beta cells [5]. Glucotoxicity, the toxic effect of hyperglycemia on beta cells, accelerates apoptosis (programmed cell death) and reduces their capacity to secrete insulin [6]. Every episode of severe hyperglycemia can contribute to the permanent loss of precious beta cells.

The DCCT study showed that intensive therapy, with stricter glycemic targets, slows the rate of C-peptide decline, so it persists for longer [5]. People with HbA1c below 7% (53 mmol/mol) in the first year after diagnosis maintain better residual beta cell function in the long term [9].

Yes, there are medicines being studied to preserve beta cells, although most are still experimental [10]. Teplizumab can delay the loss of beta cell function by 2–3 years when given in the early stages [11]. Limited availability remains a major barrier. Other therapies under study include monoclonal antibodies (anti-CD3, anti-CD20), selective immunosuppressants (sirolimus, tacrolimus) and tolerance-induction therapies (oral insulin, GAD vaccine) [10].

Taking part in clinical trials can offer access to these experimental therapies, but enrollment depends on strict criteria: your age, the time since diagnosis and the beta cell function you still have. Many of these therapies act on the immune system, so they can cause side effects, among them a higher risk of infection. The benefits and the risks are weighed together with your medical team before enrollment.

Residual beta cells can survive for years or even decades after diagnosis, although their output becomes clinically negligible [12]. Studies using ultrasensitive C-peptide assays show that around 40% of people with type 1 diabetes of more than 10 years still have minimal detectable insulin production [13]. This tiny output, even when it is insufficient for glycemic control, is beneficial.

Factors that influence beta cell survival include an older age at onset, better glycemic control, the absence of additional autoimmune diseases and, possibly, protective genetic factors [12]. Beta cells may persist in a "dormant" state, with minimal output, but still viable [14]. Current research is exploring how to reactivate these dormant cells.

Residual beta cell function is measured by assaying C-peptide, a molecule released by beta cells in amounts equal to insulin [2]. Regardless of any insulin injected from outside, C-peptide reflects only your own (endogenous) production. The test is generally done in the morning, fasting (basal value) or after stimulation with a standardized mixed meal (more sensitive) [2].

In the context of type 1 diabetes, C-peptide values are interpreted as below 0.02 nmol/L (0.06 ng/mL) for total absence; 0.02–0.2 nmol/L (0.06–0.6 ng/mL) for minimal function; and above 0.2 nmol/L (0.6 ng/mL) for good secretory function (in context) [2]. Annual testing in the first five years shows how quickly your own insulin production is falling [13]. The result tells you what to expect in the years ahead and helps your medical team adjust your treatment plan. The cost of the test is reasonable.

Preserving any residual beta cell function, even a minimal amount, brings major benefits [3]. People with detectable C-peptide have 50% fewer severe hypoglycemias, a reduced risk of ketoacidosis, lower glycemic variability and a better HbA1c, all with less effort [3]. Residual function provides a safety net that protects you in difficult situations.

In the long term, the presence of C-peptide is associated with a delay in the onset of chronic complications [4]. That is why any strategy that preserves beta cell function, even partially, is worth considering.

Diet can influence beta cell survival through several mechanisms. A moderate low-carbohydrate diet (100–150 g of carbohydrate a day) reduces the need for insulin and the secretory stress on beta cells; any change in carbohydrate intake requires the insulin doses to be readjusted, otherwise hypoglycemia follows [6]. Avoiding post-meal blood glucose spikes through smart food choices (low glycemic index, fiber, protein) minimizes glucotoxicity [6].

Intermittent fasting or intermittent calorie restriction are being studied for their regenerative potential, but the evidence is preliminary [15]. In someone treated with insulin, fasting can cause severe hypoglycemia, so it should not be started without lowering the doses and monitoring closely. Avoid extreme diets, which can destabilize glycemic control.